Jason C Beland, MD - Cancer Treatment Centers of America

Leslie Popplewell, MD is a hematologist oncologist at City of Hope Cancer Center Atlanta (formerly Cancer Treatment Centers of America [CTCA]). She is the Hematology and Blood and Marrow Transplant Medical Director, with a focus on treating patients with blood cancers, especially lymphoma, at locations in both Newnan, GA. In her director role, Dr. Popplewell collaborates with a multidisciplinary team to build and grow the hospital's bone marrow and stem cell transplant (BMT) program. She especially appreciates the way City of Hope approaches its bone marrow transplant program-rather than a window into a patient's journey just for a transplant, she's had the opportunity to be with them through the entire process.

Beomjune B. Kim, DMD, MD, FACS is a head and neck oncology and microvascular surgeon at City of Hope Cancer Center Atlanta (formerly Cancer Treatment Centers of America [CTCA]). Dr. Kim provides comprehensive medical and surgical care for patients with cancer and other diseases that affect the head and neck. He is part of the team addressing the complex surgical needs of head and neck cancer patients, and those needing reconstructive surgery. "I was drawn to City of Hope because of their commitment to provide personalized cancer care through a multidisciplinary team approach, my own values are completely aligned with their philosophy on patient care, to treat patients as you would want any member of your own family treated."

Kristin Higgins, M.D. is a radiation oncologist at City of Hope Cancer Center Atlanta (formerly Cancer Treatment Centers of America [CTCA]). Dr. Higgins is the Chief Clinical Officer, leading the hospital's efforts supporting advanced cancer care access and innovation, while also partnering with department chairs to lead physician recruitment and clinical growth. In her dual appointment as a Professor of Radiation Oncology for City of Hope Atlanta, she continues the clinical practice, specializing in the treatment of lung cancer. Collaborating on a team of cancer experts committed to expanding access to quality cancer care remains a driving force behind Dr. Higgins' research interest in innovative combination radiotherapy treatments.